Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial. uri icon

authors

  • Ledermann, Jonathan A
  • Safra, Tamar
  • Matei, Daniela
  • Fielding, Anitra
  • Spencer, Stuart
  • Rowe, Philip
  • Lowe, Elizabeth
  • Hodgson, Darren
  • Sovak, Mika A
  • Matulonis, Ursula
  • Harter, Philipp
  • Gourley, Charlie
  • Friedlander, Michael
  • Vergote, Ignace
  • Rustin, Gordon
  • Scott, Clare
  • Meier, Werner
  • Shapira-Frommer, Ronnie

publication date

  • January 1, 2016